Debio-025, a cyclophilin inhibitor, has been shown to improve muscle pathology associated with several mouse models of muscular dystrophy, including Sgcd-/- mice, through its action of preventing MPTP-induced myofiber necrosis [11,17]. This evidence concerns the gene PPIB and muscular dystrophy.